Who is sponsoring NCT04255550?

NCT04255550 is sponsored by Cairo University.

What drugs are being tested in NCT04255550?

Interventions in NCT04255550: Esophageal doppler.

What condition does NCT04255550 study?

NCT04255550 studies Electrical Cardiometry VS Esophageal Doppler.

Is NCT04255550 still recruiting?

NCT04255550 is currently completed. Last updated 19 July 2022.

Last reviewed 2022-07-19 · How we verify

NCT04255550

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hemodynamic Monitoring and Correlation Between Electrical Cardiometry and Esophageal Doppler in Patients Undergoing Major Abdominal Surgery

Completed Last updated 19 July 2022

What this trial tests

trial testing Esophageal doppler in Electrical Cardiometry VS Esophageal Doppler in 35 participants. Completed in 30 December 2020.

Timeline

9 April 2019

Primary endpoint
15 December 2020

30 December 2020

Quick facts

Lead sponsor	Cairo University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	35
Start date	9 April 2019
Primary completion	15 December 2020
Estimated completion	30 December 2020
Sites	1 location across Egypt

Drugs / interventions tested

Esophageal doppler

Conditions studied

Electrical Cardiometry VS Esophageal Doppler — all drugs for Electrical Cardiometry VS Esophageal Doppler →

Sponsor

Cairo University

Who can join

Adults 20 to 60, any sex, with Electrical Cardiometry VS Esophageal Doppler. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to correlate hemodynamic monitoring between noninvasive Electrical Cardiometry and minimally invasive Esophageal Doppler in patients undergoing major abdominal surgery

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Esophageal doppler

Trials testing the same drug.

NCT06797713 — Effect of Targeted Fluid Therapy on Postoperative Cognitive Dysfunction. · NA · completed

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04255550 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 19 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04255550.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing